UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023897
Receipt number R000027376
Scientific Title Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases
Date of disclosure of the study information 2016/09/01
Last modified on 2023/03/09 01:49:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases

Acronym

Prospective study of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases

Scientific Title

Prospective study of evaluating the efficacy and safety of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases

Scientific Title:Acronym

Prospective study of Radium-223 dichloride in patients with castration-resistant prostate cancer and bone metastases

Region

Japan


Condition

Condition

castration-resistant prostate cancer with bone metastases

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the clinical effectiveness of Radium-223 dichloride for castration-resistant prostate cancer with bone metastases.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

change rate of PSA at six month after completion of Radium-223 dichloride therapy

Key secondary outcomes

Rates of Adverse events, improvement rate of pain from bone metastases, bone metastases progressive free survival, distant metastases free survival excluding bone metastases, pattern of progression, overall survival


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Radium-223 dichloride (55 kBq/kg) on day 1 every 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male

Key inclusion criteria

1) Confirmation of castration-resistant prostate cancer and bone metastases
2) Age from 20 to 80 years old
3) Preserved hematologic function within 28 days as follows;
i) neutrophile count >=1,500/mm3
ii) hemoglobin >= 10.0 g/dL
iii) platelet count >=100,000/mm3
4) Written informed consent is taken.

Key exclusion criteria

1) organ metastases excluding bone metastases
2) active concomitant malignancy
3) inflammatory bowel disease (Crohn's disease or ulcerative colitis)
4) use of chemotherapy with myelosuppresion reaction at the same time
5) difficult to participate with the trial, having mentel disorder or psychiatric symptoms
6) immuno-suppression treatment

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tetsuo
Middle name
Last name Momma

Organization

National Hospital Organization Saitama Hospital

Division name

Urology

Zip code

351-0102

Address

2-1, Suwa, Wako-shi, Saitama, 351-0102, JAPAN

TEL

048-462-1101

Email

monma-jua@umin.ac.jp


Public contact

Name of contact person

1st name Tetsuo
Middle name
Last name Momma

Organization

National Hospital Organization Saitama Hospital

Division name

Urology

Zip code

351-0102

Address

2-1, Suwa, Wako-shi, Saitama, 351-0102, JAPAN

TEL

048-462-1101

Homepage URL


Email

monma-jua@umin.ac.jp


Sponsor or person

Institute

National Hospital Organization Saitama Hospital

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Saitama Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, National Hospital Organization Saitama Hospital

Address

2-1, Suwa, Wako-shi, Saitama, 351-0102, JAPAN

Tel

048-462-1101

Email

hiizuka@wakho.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 08 Month 01 Day

Date of IRB

2016 Year 09 Month 01 Day

Anticipated trial start date

2016 Year 09 Month 02 Day

Last follow-up date

2022 Year 08 Month 31 Day

Date of closure to data entry

2022 Year 12 Month 31 Day

Date trial data considered complete

2023 Year 01 Month 31 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 09 Month 01 Day

Last modified on

2023 Year 03 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027376


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name